X4 Pharmaceuticals Inc. (XFOR): Total Asset Value of Company
X4 Pharmaceuticals (XFOR) specializes in the therapy of rare immune pathologies, mitigating the risks of a narrow portfolio by launching a key oral agent into the US market. Financial flow stability is strengthening as the approved drug undergoes commercialization. Total assets amount to 179.13, while the daily price action reflects the use of external CDMO facilities for production, which eliminates capacity downtime at the Massachusetts centers.
Comprehensive metric breakdowns and analytics for X4 Pharma (XFOR)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio X4 Pharmaceuticals|XFOR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio X4 Pharmaceuticals, Inc|XFOR - Company Aggregate Debts|Debts to Book Capitalization X4 Pharmaceuticals, Inc|XFOR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings X4 Pharmaceuticals
Fundamental valuation:XFOR, x4pharma.com
Total assets, reverse-calculated via return on assets (ROA), determine the aggregate value of resources and liabilities, allowing for an assessment of the actual scale of the business regardless of market volatility. By analyzing the assets of X4 Pharmaceuticals (XFOR) through ROA, an investor separates operational resilience from random spikes, which is critically important for X4 Pharmaceuticals (XFOR) in ensuring the complex logistics of drugs for the treatment of rare immune disorders.
Competitors of X4 Pharmaceuticals (XFOR)
ARGX (argenx.com) - Aggregate Asset Value|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|PVLA - Company Assets|Savara Corp (SVRA) - Cumulative Company Assets|RIGL (Rigel Corp) - Total Business Assets|ANAB (AnaptysBio, Inc.) - Total Business Assets|astriatx.com - Cumulative Company Assets|Aggregate Asset Value enGene|RAPT Therapeutics Inc. - Aggregate Company Assets|Total Asset Value of Company JBIO|ACRS (Aclaris Therapeutics, Inc) - Company Total Assets|Aggregate Asset Value KYTX (Kyverna Therapeutics)|Company Total Assets tizianalifesciences.com TLSA|CABA - Company Total Assets|Aggregate Company Assets VTYX (Ventyx Biosciences Inc.)|Theratechnologies Inc (THTX) - Aggregate Asset Value|Aggregate Company Assets Avalo Therapeutics Inc|ELDN (Eledon Pharmaceuticals) - Cumulative Company Assets|Company Total Assets agenusbio.com|Company Total Assets CLYM|Company Total Assets Zura Bio Ltd ZURA|Cumulative Company Assets ATYR (aTyr)|Adagene Inc (ADAG) - Company Total Assets|IMA: Company Assets|STTK - Cumulative Company Assets|EQ (equilliumbio.com) - Company Total Assets|CNTB: Cumulative Company Assets|IMUX (Immunic Therapeutics) - Aggregate Business Assets|Atara Biotherapeutics Inc (ATRA) - Company Total Assets|Company Total Asset Base IFRX|Company Total Assets adicetbio.com ACET|Cumulative Company Assets CELU (Celularity)|Company Total Assets INmune Bio Inc INMB|BRNS - Company Total Assets|KZR: Aggregate Company Assets|SAB Biotherapeutics (SABS) - Aggregate Company Assets|AKTX - Aggregate Company Assets|Company Total Asset Base ENLV|Cumulative Company Assets QTTB (Q32 Bio Corp)|Total Business Assets GOVX|EDSA: Company Total Assets|Total Asset Value of Company iBio, Inc. IBIO|Carisma Therapeutics Inc (CARM) - Aggregate Company Assets|XTLB - Company Assets|Aggregate Company Assets BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Aggregate Asset Value|Aggregate Company Assets APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech Inc.) - Total Asset Value of Company|ADTX: Company Total Assets|Aggregate Asset Value GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|Company Total Assets ReShape Lifesciences HIND|Aggregate Company Assets REVB|INDP - Aggregate Asset Value|scinai.com (SCNI) - Aggregate Company Assets|CALI: Cumulative Company Assets|Affimed N.V. (AFMD) - Company Total Assets|Company Total Assets ALLK|HOOK: Cumulative Company Assets|Aggregate Asset Value IGMS|Company Total Assets iteostherapeutics.com|Company Total Asset Base Ocean Biomedical OCEA|TCBP - Aggregate Company Assets|THRD - Cumulative Company Assets